Business Context and Reporting Period
This Form 8-K is filed by The Clorox Company (CLX) on July 31, 2020, reporting events occurring on August 1 and August 3, 2020. The filing primarily addresses the announcement of financial results for the fourth quarter and fiscal year ended June 30, 2020, and significant changes in executive leadership.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing the full financial results for the quarter and fiscal year ended June 30, 2020. However, the text of this 8-K does not explicitly state specific values for revenue, profit, cash flow, margins, debt, or liquidity. It notes the inclusion of supplemental financial information (Exhibit 99.3) and recast segment data (Exhibit 99.4) but does not reproduce the numerical figures within the body of this report.
Material Changes
- Executive Leadership Transition: Benno Dorer, the current Chief Executive Officer, will step down effective September 14, 2020. He will continue to serve as the Board's executive chair.
- CEO Appointment: Linda Rendle, a 17-year company veteran and current President, was elected CEO effective September 14, 2020.
- Compensation Adjustment: In connection with her new role, Ms. Rendle's base salary was increased to $1,075,000, and her short-term incentive target was set at 150% of her salary, effective September 14, 2020.
- Segment Recasting: Beginning with the fourth quarter of fiscal year 2020, the company combined the Dietary Supplements and Digestive Health SBUs into the Vitamins, Minerals and Supplements SBU, and the Home Care and Laundry SBUs into the Cleaning SBU. These, along with Professional Products, now form the new Health and Wellness reportable segment.
Guidance, Outlook, and Risks
The filing text does not provide specific forward-looking guidance, management commentary on future outlook, or a detailed discussion of risks and contingencies. It directs readers to the attached press releases (Exhibits 99.1 and 99.2) for the full text of the financial results announcement and the leadership transition details.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q4 and FY2020 revenue, earnings, and cash flow figures.
- Examine Exhibit 99.4 to understand the impact of the segment recasting on historical comparability for fiscal years 2018, 2019, and 2020.
- Verify the transition timeline for the CEO change (effective September 14, 2020) and the continued role of Benno Dorer as executive chair.
- Confirm the details of the new Health and Wellness reportable segment composition.